Patients who present with NSTEMI have a lower 6-month mortality rate than those who present with unstable angina. Morbidity and mortality further depend on the degree of troponin elevation as well as comorbid conditions such as the severity of diabetes, presence of peripheral vascular disease, presence of renal dysfunction, and dementia.